Apple Ordered to Pay Masimo $634 Million in Blood-Oxygen Patent Ruling

- Latest News - November 15, 2025
apple watches are displayed at an apple store in new york city us april 15 2025 photo reuters
18 views 4 mins 0 Comments

Apple Watch Faces Legal Setback: Understanding the Masimo Patent Dispute

In recent news that sent ripples through the tech community, a federal jury in California ruled that Apple must pay a hefty $634 million to Masimo, a company specializing in medical monitoring technology. This decision stems from a claim that Apple Watch features, specifically those related to blood-oxygen readings and heart rate notifications, infringed on Masimo’s patents.

Masimo’s spokesperson commented that this verdict marks a significant step in their ongoing efforts to safeguard their innovations. Over the past six years, Masimo had filed lawsuits against Apple on multiple occasions, asserting over 25 patents, though most of these claims were found invalid. Interestingly, the patent at the heart of this case expired in 2022 and pertains to historical patient monitoring technology from decades ago.

What’s at Stake?

This legal battle isn’t just about money; it highlights a broader issue of intellectual property rights within the tech industry. Apple has faced considerable scrutiny over claims that it not only infringed Masimo’s patents but also poached its employees to develop similar technology. The feud has been fierce, resembling a high-stakes chess game where each move could lead to significant changes in product offerings and strategies.

The implications go beyond just one lawsuit. A previous ruling by the U.S. International Trade Commission (ITC) led to a ban on the import of Apple’s Series 9 and Ultra 2 smartwatches due to patent violations. To circumvent this, Apple removed the contentious blood-oxygen reading technology from its devices, indicating the depth of Masimo’s claims and the potential repercussions for Apple’s innovations.

Ongoing Legal Challenges

Even with this recent ruling, the conflict isn’t over. The ITC has recently initiated new proceedings to assess whether Apple’s updated products will still face import bans. In addition, Masimo has launched a lawsuit concerning the most recent ITC ruling, and Apple is simultaneously appealing the import ban through federal courts.

Interestingly enough, this isn’t the only legal skirmish Apple is involved in. Earlier, the company managed a minor win in Delaware, where a jury awarded them $250 related to allegations of design patent infringements by Masimo’s smartwatches. With these legal challenges piling up, it’s evident that both companies are entrenched in a multi-faceted battle for market dominance.

What Lies Ahead?

With the tech landscape continuously evolving, it will be interesting to see how these legal proceedings evolve. As consumers, we might wonder how such disputes affect the gadgets we love and rely on daily. Will Apple innovate its way out of this issue, or will Masimo’s claims lead to more significant changes in Apple’s product offerings?

As we keep an eye on this unfolding saga, let’s remember that these legal battles are also about protecting innovation and ensuring fair competition in the tech market. If you’re keen to stay updated on tech news, trends, and insights, consider connecting with Pro21st for more in-depth discussions. Your journey through the world of technology just got a little more engaging!

At Pro21st, we believe in sharing updates that matter.
Stay connected for more real conversations, fresh insights, and 21st-century perspectives.

TAGS:
Comments are closed.